
Standard BioTools Investor Relations Material
Latest events

Q1 2025
Standard BioTools
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Standard BioTools Inc
Access all reports
Standard BioTools Inc. (formerly known as Fluidigm Corporation) is a life sciences technology company that provides advanced tools and systems for biological research. The company specializes in products for mass cytometry, genomics, and other high-throughput techniques that enable researchers to study cell behavior, gene expression, and protein interactions at the molecular level. Standard BioTools' solutions support research in areas such as cancer, immunology, and drug discovery. The company is headquartered in South San Francisco, California, and its shares are listed on the NASDAQ.
Key slides for Standard BioTools Inc


Jefferies London Healthcare Conference 2024
Standard BioTools Inc


Q1 2025
Standard BioTools Inc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
LAB
Country
🇺🇸 United States